BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36612071)

  • 21. The Better Survival of MSI Subtype Is Associated With the Oxidative Stress Related Pathways in Gastric Cancer.
    Cai L; Sun Y; Wang K; Guan W; Yue J; Li J; Wang R; Wang L
    Front Oncol; 2020; 10():1269. PubMed ID: 32850385
    [No Abstract]   [Full Text] [Related]  

  • 22. Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers.
    Derks S; Liao X; Chiaravalli AM; Xu X; Camargo MC; Solcia E; Sessa F; Fleitas T; Freeman GJ; Rodig SJ; Rabkin CS; Bass AJ
    Oncotarget; 2016 May; 7(22):32925-32. PubMed ID: 27147580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features.
    Liu X; Choi MG; Kim K; Kim KM; Kim ST; Park SH; Cristescu R; Peter S; Lee J
    Pathol Res Pract; 2020 Apr; 216(4):152881. PubMed ID: 32089413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus and microsatellite instability in gastric carcinogenesis.
    Chang MS; Lee HS; Kim HS; Kim SH; Choi SI; Lee BL; Kim CW; Kim YI; Yang M; Kim WH
    J Pathol; 2003 Apr; 199(4):447-52. PubMed ID: 12635135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological characteristics of Epstein-Barr virus and microsatellite instability subtypes of early gastric neoplasms classified by the Japanese and the World Health Organization criteria.
    Tanabe H; Mizukami Y; Takei H; Tamamura N; Omura Y; Kobayashi Y; Murakami Y; Kunogi T; Sasaki T; Takahashi K; Ando K; Ueno N; Kashima S; Yuzawa S; Hasegawa K; Sumi Y; Tanino M; Fujiya M; Okumura T
    J Pathol Clin Res; 2021 Jul; 7(4):397-409. PubMed ID: 33750036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated microsatellite instability at selected tetranucleotide (EMAST) repeats in gastric cancer: a distinct microsatellite instability type with potential clinical impact?
    Herz AL; Wisser S; Kohlruss M; Slotta-Huspenina J; Jesinghaus M; Grosser B; Steiger K; Novotny A; Hapfelmeier A; Schmidt T; Gaida MM; Weichert W; Keller G
    J Pathol Clin Res; 2022 May; 8(3):233-244. PubMed ID: 35099128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma.
    Min BH; Tae CH; Ahn SM; Kang SY; Woo SY; Kim S; Kim KM
    Gastric Cancer; 2016 Jul; 19(3):852-9. PubMed ID: 26265391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alteration in stemness causes exclusivity between Epstein-Barr virus-positivity and microsatellite instability status in gastric cancer.
    Kim Y; Shin YJ; Wen X; Cho NY; Li M; Kim YJ; Song SH; Kang GH
    Gastric Cancer; 2021 May; 24(3):602-610. PubMed ID: 33386473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Young-onset gastric cancer and Epstein-Barr Virus (EBV) - a major player in the pathogenesis?
    Moore A; Hikri E; Goshen-Lago T; Barkan T; Morgenstern S; Brook E; Maderer A; Roth W; Gordon N; Kashtan H; Brenner B; Moehler M; Aharon IB
    BMC Cancer; 2020 Jan; 20(1):34. PubMed ID: 31937281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host immune response index in gastric cancer identified by comprehensive analyses of tumor immunity.
    Park C; Cho J; Lee J; Kang SY; An JY; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kim ST; Park SH; Park JO; Kang WK; Sohn I; Jung SH; Kang MS; Kim KM
    Oncoimmunology; 2017; 6(11):e1356150. PubMed ID: 29147610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer.
    Zhang L; Wang Y; Li Z; Lin D; Liu Y; Zhou L; Wang D; Wu A; Li Z
    Diagn Pathol; 2021 May; 16(1):38. PubMed ID: 33933102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low level of microsatellite instability correlates with short disease-free survival of gastric cancer patients undergoing neoadjuvant chemotherapy.
    Jiang D; Shu C; Zhang W; Sun L; Zhang M; He Y; Owen G; Jin W; He D; Deng X; Liu X
    Virchows Arch; 2021 Feb; 478(2):231-240. PubMed ID: 32588133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection.
    Chiaravalli AM; Feltri M; Bertolini V; Bagnoli E; Furlan D; Cerutti R; Novario R; Capella C
    Virchows Arch; 2006 Mar; 448(3):344-53. PubMed ID: 16261379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoscore is a strong predictor of survival in the prognosis of stage II/III gastric cancer patients following 5-FU-based adjuvant chemotherapy.
    Yun S; Koh J; Nam SK; Kwak Y; Ahn SH; Do Park J; Kim HH; Kim WH; Lee HS
    Cancer Immunol Immunother; 2021 Feb; 70(2):431-441. PubMed ID: 32785776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastric cancer molecular classification and adjuvant therapy: Is there a different benefit according to the subtype?
    Ramos MFKP; Pereira MA; Amorim LC; de Mello ES; Faraj SF; Ribeiro U; Hoff PMG; Cecconello I; de Castria TB
    J Surg Oncol; 2020 Apr; 121(5):804-813. PubMed ID: 31797380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) Gastric Cancer Molecular Classifications and Their Association with Clinicopathological Characteristics and Overall Survival in Moroccan Patients.
    Nshizirungu JP; Bennis S; Mellouki I; Sekal M; Benajah DA; Lahmidani N; El Bouhaddouti H; Ibn Majdoub K; Ibrahimi SA; Celeiro SP; Viana-Pereira M; Munari FF; Ribeiro GG; Duval V; Santana I; Reis RM
    Dis Markers; 2021; 2021():9980410. PubMed ID: 34367379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.
    Haag GM; Czink E; Ahadova A; Schmidt T; Sisic L; Blank S; Heger U; Apostolidis L; Berger AK; Springfeld C; Lasitschka F; Jäger D; von Knebel Doeberitz M; Kloor M
    Int J Cancer; 2019 Apr; 144(7):1697-1703. PubMed ID: 30499151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study.
    Hewitt LC; Inam IZ; Saito Y; Yoshikawa T; Quaas A; Hoelscher A; Bollschweiler E; Fazzi GE; Melotte V; Langley RE; Nankivell M; Cunningham D; Allum W; Hutchins GG; Grabsch HI
    Eur J Cancer; 2018 May; 94():104-114. PubMed ID: 29550565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphoepithelioma-like gastric carcinoma: clinicopathological characteristics and infection status.
    Ramos MFKP; Pereira MA; Dias AR; Faraj SF; Zilberstein B; Cecconello I; de Mello ES; Ribeiro Junior U
    J Surg Res; 2017 Apr; 210():159-168. PubMed ID: 28457323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microsatellite Instability and Effectiveness of Adjuvant Treatment in pT1N1 Gastric Cancer: A Multicohort Study.
    Oh N; Kim H; Kim KM; Cheong JH; Lee J; Noh SH; Sohn TS; Choi YY; An JY
    Ann Surg Oncol; 2021 Dec; 28(13):8908-8915. PubMed ID: 34401986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.